The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in the waning days of the Biden administration. “While it is crucial that the ...

Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss By HealthDay Staff HealthDay ReporterWEDNESDAY, April 22, 2026 (HealthDay News) — A new effort to prepare for future bird flu ...

Moderna has secured European Commission approval for its combined COVID-19 and influenza vaccine, mCombriax, for adults aged 50 and older, marking its fourth marketed product in the EU. The decision ...

Moderna (MRNA) announced on Wednesday that the company has initiated dosing in a Phase 3 trial designed to evaluate its messenger RNA-based bird flu vaccine candidate, mRNA-1018, in the U.S. and U.K.

Theresa is the lead Morning Rounds writer, and her stories focus on gender-affirming care, reproductive health, and mental health. You can reach Theresa on Signal at theresagaff.97. Get your daily ...

The U.S. government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu, caused by the H5N1 virus, in humans as cases in dairy cows ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Experts warn that while the virus is "evolving and spreading" rapidly among animals, and does not yet easily transmit between people, the potential for human-to-human transmission must be treated "as ...

The company said the first participants have already received a shot. HealthDay News — A new effort to prepare for future bird flu outbreaks is moving forward, despite a major funding setback. The ...

FILE PHOTO: People pose with syringe with needle in front of displayed Moderna logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo April 21 (Reuters) - ...